Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · Real-Time Price · USD
7.83
-2.52 (-24.35%)
At close: Aug 13, 2025, 4:00 PM
8.29
+0.46 (5.87%)
Pre-market: Aug 14, 2025, 8:56 AM EDT
Vicarious Surgical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Vicarious Surgical stock has a target of 7.00, which predicts a -10.60% decrease from the current stock price of 7.83.
Price Target: $7.00 (-10.60%)
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Vicarious Surgical is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Hold Maintains $8.5 → $7 | Hold | Maintains | $8.5 → $7 | -10.60% | Aug 13, 2025 |
Piper Sandler | Piper Sandler | Hold Maintains $11 → $8.5 | Hold | Maintains | $11 → $8.5 | +8.56% | Mar 18, 2025 |
Piper Sandler | Piper Sandler | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +34.10% | Nov 13, 2024 |
Piper Sandler | Piper Sandler | Hold Maintains $30 → $12 | Hold | Maintains | $30 → $12 | +53.26% | Aug 13, 2024 |
Morgan Stanley | Morgan Stanley | Hold Maintains $18 → $10 | Hold | Maintains | $18 → $10 | +27.71% | Jul 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-9.63
from -10.74
EPS Next Year
-7.14
from -9.63
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 37.8M | ||
Avg | n/a | n/a | 22.4M | ||
Low | n/a | n/a | 8.7M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -9.09 | -3.92 | -2.96 |
Avg | -9.63 | -7.14 | -5.63 |
Low | -10.18 | -9.99 | -9.22 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.